Sodium‐glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b?Magdalena Kaczor, Dorota Wesół‐Kucharska, Elżbieta Ciara et al.|JIMD Reports|2022Cited by 20
Clinical characteristics and long-term outcomes of patients with glycogen storage disease type 1b: a retrospective multi-center experience in PolandMagdalena Kaczor, Dariusz Rokicki, Dorota Wesół‐Kucharska et al.|Pediatric Endocrinology Diabetes and Metabolism|2022Cited by 13